Skip to main content
Top
Published in: Clinical Rheumatology 12/2022

30-07-2022 | Systemic Sclerosis | Clinical Image

The groove sign in eosinophilic fasciitis

Authors: Marion Camard, Thierry Maisonobe, Edouard Flamarion

Published in: Clinical Rheumatology | Issue 12/2022

Login to get access

Excerpt

A 56-year-old previously healthy man presented with a 1-month history of swelling of the extremities, with a 7-kg weight gain. Physical examination revealed bilateral pitting edema in the forearms and legs, with erythema and skin induration. On limb elevation, he was noted to have depression along the course of the superficial veins, consistent with the groove sign (Fig. 1A and B). Blood test revealed eosinophilia (6 400 cells per mm3) with normal creatine phosphokinase level. Magnetic resonance imaging showed an edematous infiltrate of subcutaneous tissues and an increased signal in the deep fascia (Fig. 1C). Skin-to-muscle biopsy demonstrated inflammatory infiltrate (mostly constituted of lymphocytes TCD8, plasma cells and eosinophils) along the fascia, with an extension to the adjacent muscle (Fig. 1D).
Metadata
Title
The groove sign in eosinophilic fasciitis
Authors
Marion Camard
Thierry Maisonobe
Edouard Flamarion
Publication date
30-07-2022
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 12/2022
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-022-06311-y

Other articles of this Issue 12/2022

Clinical Rheumatology 12/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine